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Abstract We have previously found that transforming growth
factor-L (TGF-L) induces an increase in radical oxygen species
(ROS) production that mediates its apoptotic effects in fetal
hepatocytes. In this paper we show that TGF-L activates p38
mitogen-activated protein kinase (p38MAPK) and ROS may
be responsible for this activation. Activation of p38MAPK
occurs late, coincident with the maximal production of ROS,
it is inhibited by radical scavengers and it is accentuated by
the presence of glutathione synthesis inhibitors. However,
p38MAPK does not appear to be involved in any of the apoptotic
events: loss of Bcl-xL levels, cytochrome c release, cleavage of
caspase substrates and loss of cell viability. ß 2001 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Transforming growth factor-L (TGF-L) plays an important
role mediating hepatocyte apoptosis [1,2]. We have previously
found that TGF-L induces an increase in radical oxygen spe-
cies (ROS) production and a decrease in intracellular gluta-
thione content [2,3], which precedes the loss of mitochondrial
transmembrane potential (vim), the release of cytochrome c
and the activation of caspase-3 [4] in rat fetal hepatocytes.
TGF-L treatment produces a decrease in both protein and
mRNA levels of Bcl-xL [4,5]. Presence of radical scavengers
blocks the decrease in Bcl-xL levels, vim collapse, cytochrome
c release and activation of caspase-3 [4], which indicates that
during the apoptosis mediated by TGF-L in fetal hepatocytes,
ROS might be responsible for the decrease in Bcl-xL mRNA
levels and the mitochondrial-dependent cell death.
Members of the mitogen-activated protein (MAP) kinase
family are involved in signal transduction of apoptosis as
well as cell growth and di¡erentiation [6]. c-Jun N-terminal
kinases (JNKs) and p38MAP kinases (p38MAPKs) appear to
be preferentially activated by cytotoxic stress (including oxi-
dative stress) and by pro-in£ammatory cytokines [6^8].
p38MAPKs have been implicated both as positive and nega-
tive regulators of cell survival [8] and di¡erent p38 isoforms
seem to account for these opposite e¡ects. In particular,
p38MAPK activity plays a critical role in nitric oxide-medi-
ated cell death in neurons by stimulating Bax translocation to
the mitochondria [9] and contributes to the UV-induced apo-
ptosis in keratinocytes by mediating the release of mitochon-
drial cytochrome c into the cytosol [10]. In rat fetal brown
adipocytes, p38MAPK mediates tumor necrosis factor-K-in-
duced growth inhibition and apoptosis [11]. Bone morphoge-
netic protein 2, a member of the TGF-L superfamily, induces
apoptosis by activating TGF-activated kinase (TAK1) and
subsequent phosphorylation of p38MAPK in mouse hybrid-
oma MH60 cells [12]. In contrast, activation of p38MAPK
protects primary neonatal rat cardiomyocytes from anisomy-
cin-induced apoptosis [13] and activation of the transcription
factor MEF2 by p38MAPK has been shown to be required
for the survival of developing neurons [14].
p38MAPK pathway is activated by TGF-L in di¡erent cell
types [15^19]. Although it appears to be established that
p38MAPK could play a role in the TGF-L-induced chemo-
tactic responses [15] and regulation of gene expression [16^19],
nothing is known about its possible role in its apoptotic ef-
fects. In the current study we have used rat fetal hepatocytes
in primary culture to determine how TGF-L1 activates
p38MAPK and whether this activation is related or not to
the oxidative stress and apoptosis induced by TGF-L1 in these
cells.
2. Materials and methods
2.1. Isolation of fetal rat hepatocytes and culture
Hepatocytes from 20 day old fetal Wistar rats were isolated by
collagenase disruption, plated in arginine free medium 199, supple-
mented with ornithine (200 WM), fetal calf serum (10%), penicillin
(120 Wg/ml) and streptomycin (100 Wg/ml) and incubated as previously
described [2].
2.2. Western blot analysis
To detect active p38MAPK, Western blot analysis was performed
as previously described [11]. An anti-phospho-p38MAPK antibody
from New England Biolabs, and an anti-p38MAPKK antibody from
Santa Cruz were used. Bcl-x, Bid and albumin protein levels were
analyzed as described [4], using an anti-Bcl-x polyclonal antibody
from Santa Cruz, anti-Bid polyclonal antibody from RpD Systems
and anti-albumin polyclonal antibody from Nordic Immunological
Lab. To analyze cytochrome c release, mitochondria were isolated
from cytosol by digitonin treatment as described [20]. Cytochrome c
0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 2 5 5 4 - 6
*Corresponding author. Fax: (34)-91-3941779.
E-mail: isabelf@eucmax.sim.ucm.es
Abbreviations: MAPK, mitogen-activated protein kinase; TGF-L,
transforming growth factor-L ; ROS, radical oxygen species
FEBS 24970 14-6-01
FEBS 24970 FEBS Letters 499 (2001) 225^229
levels in the mitochondrial fraction were analyzed by Western blot [4]
with a monoclonal antibody from Pharmingen.
2.3. MAPKAPK2 kinase assay
MAPKAPK2 kinase activity was assayed in immunocomplexes,
prepared with an anti-MAPKAPK2 antibody from StressGen Bio-
technologies Corp. and human recombinant Hsp27 protein (StressGen
Biotechnologies Corp.) was used as substrate [11]. Phosphorylated
Hsp27 was visualized by autoradiography.
2.4. Glutathione determination
Cellular glutathione was extracted and analyzed as described [2,3].
Using GSH as standard, glutathione content is expressed as pmol/Wg
protein and represented in ¢gures as percentage with respect to con-
trol cells.
2.5. Analysis of caspase-3 and caspase-8 activities
Cells were lysed as previously described [5]. For caspase-3 activity,
reaction mixture contained 20 mM HEPES pH 7.0, 10% glycerol,
2 mM dithiothreitol (DTT), 30 Wg protein/condition and 20 WM
Ac-DEVD-AMC substrate. Reaction mixture for caspase-8 activity
contained 20 mM PIPES pH 7.2, 100 mM NaCl, 10 mM DTT,
1 mM EDTA, 0.1% (w/v) CHAPS, 10% sucrose, 70 Wg protein/con-
dition and 22.6 WM Ac-IETD-AFC substrate. After 2 h of incubation
in the dark, enzymatic activity was measured in a Microplate Fluo-
rescence Reader FL600 (Bio-Tek). A unit of caspase activity is de¢ned
as the amount of active enzyme necessary to produce an increase of
one arbitrary unit in the luminescence spectrophotometer after 2 h.
Protein concentration of cell lysates was determined by the Bio-Rad
protein assay kit.
2.6. Cytotoxicity assay
Cells were washed twice with phosphate-bu¡ered saline and the
remaining viable adherent cells were stained with crystal violet as
described [3]. Results are expressed as percentage of absorbance
with respect to control, untreated cells.
3. Results
3.1. TGF-L activates p38MAPK in fetal rat hepatocytes
First, we studied whether TGF-L activates p38MAPK in
fetal rat hepatocytes. We initially used high concentrations
of this factor (2 ng/ml) to observe maximal e¡ects.
p38MAPK is activated after incubation of fetal hepatocytes
with TGF-L for 5 h, but not at shorter times (Fig. 1A). We
have previously described that epidermal growth factor (EGF)
is a potent mitogen in fetal hepatocytes, which counteracts the
apoptotic response of TGF-L [21]. EGF activated p38MAPK
at short times (10^30 min) either in the absence or in the
presence of TGF-L. However, this activation was transient,
since at longer times, EGF had not any e¡ect. Interestingly,
Fig. 1. TGF-L activates p38MAPK in fetal rat hepatocytes. A: Fe-
tal hepatocytes were incubated for 10 min or 5 h in the absence (C)
or in the presence of 2 ng/ml TGF-L (T), 20 ng/ml EGF (E) or
both (E+T). After this time, proteins were extracted and analyzed
by Western blot using antibodies against the active form (P-p38)
and total form (p38). B: Dose^response e¡ect of TGF-L on
p38MAPK activation analyzed by Western blot after incubation for
5 h of fetal hepatocytes with di¡erent concentrations of TGF-L.
C: MAPKAPK2 activity in immunocomplexes and inhibition by
PD169316 (400 nM). PD169316 was added 1 h before TGF-L. In
all cases, a representative experiment of three is shown.
Fig. 2. Involvement of ROS in the activation of p38MAPK by
TGF-L. A: Cells were treated for 8 h without or with 2 ng/ml
TGF-L and without or with PD169316 (400 nM). After this time,
cells were collected and cellular glutathione was analyzed. Results
are expressed as % of control and are means þ S.E.M. of duplicate
dishes from three independent experiments. Data were compared
versus untreated cells by Student’s test; *P6 0.05. B,C: Activation
of p38MAPK was analyzed by Western blot with 30 Wg protein
from fetal hepatocytes incubated for 5 h without or with 2 ng/ml
TGF-L. B: E¡ect of the presence of radical scavengers (1 mM as-
corbate+50 WM PDTC). A representative experiment of four is
shown. C: E¡ect of the presence of an inhibitor of glutathione syn-
thesis (1 mM BSO). A representative experiment of two is shown.
D: E¡ect of 0.25 mM TBH on p38MAPK activation in fetal hepa-
tocytes. A representative experiment of two is shown.
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EGF blocked the p38MAPK activation induced by TGF-L at
5 h, which could suggest that p38MAPK is not activated
under conditions where the apoptotic program is impaired.
Activation of p38MAPK was dose-dependent, reaching a
maximum at 2 ng/ml TGF-L (Fig. 1B). This dose^response
correlates with the oxidative stress process and apoptosis in-
duced by this factor [2,4], but not with its ability to inhibit
growth, which occurs at lower concentrations [22].
Finally, we con¢rmed these results in a MAPKAPK2 assay.
MAPKAPK2, one of the p38MAPK downstream targets, was
also activated by TGF-L at 5 h. This activation was blocked
by pre-treatment with the speci¢c p38MAPK inhibitors
PD169316 (Fig. 1C) and SB203580 (results not shown). Since
PD169316 did not inhibit other kinases, whereas SB203580
also inhibited JNK (results not shown), we selected
PD169316 to be used in all the experiments described below.
3.2. Involvement of ROS in the activation of p38MAPK by
TGF-L
Since TGF-L induces ROS production and glutathione de-
pletion, which occurs after 3^6 h incubation [2^4], we decided
to examine whether p38MAPK is involved in this oxidative
stress. Fig. 2A shows that the presence of PD169316 had no
signi¢cant e¡ect on the decrease of glutathione levels induced
by TGF-L. Therefore, p38MAPK is not necessary for the oxi-
dative stress induced by TGF-L in fetal hepatocytes. We next
decided to study whether the increase in ROS could be re-
sponsible for the activation of p38MAPK. We have reported
that TGF-L-induced increase in peroxide content can be
blocked by the presence of radical scavengers, such as pyrro-
lidine carbodithoic acid (PDTC) and ascorbic acid (ASC),
which are also able to impair cell death [2,4]. Fig. 2B shows
that the presence of PDTC+ASC prevented the activation of
p38MAPK by TGF-L. Furthermore, in the presence of a pro-
oxidant, such as BSO (DL-buthionine-(S,R)-sulfoximine), an
inhibitor of glutathione synthesis that we previously used to
decrease glutathione content in fetal hepatocytes [3], the acti-
vation of p38MAPK was more accentuated (Fig. 2C). These
results indicate that the oxidative stress induced by TGF-L
could be ruling the activation of p38MAPK. We next exam-
ined whether exogenous peroxide (tert-butyl-hydroperoxide,
TBH) would be able to activate p38MAPK. As it is shown
in Fig. 2D, 0.25 mM TBH alone produced an activation of
p38MAPK. These results indicate that ROS production could
be responsible for the activation of p38MAPK by TGF-L in
fetal hepatocytes.
Fig. 3. Role of p38MAPK on Bcl-xL down-regulation and cyto-
chrome c release induced by TGF-L in fetal hepatocytes. A: After
15 h incubation of fetal hepatocytes without or with 2 ng/ml TGF-L
and without or with PD169316 (400 nM), proteins were extracted
and Bcl-xL levels were analyzed by Western blot. Albumin content
was analyzed as control. A representative experiment of three is
shown. B: Cells were incubated for 15 h under the same conditions
described in A. After this time, mitochondria were separated from
cytosol and cytochrome c content was analyzed by Western blot.
Bars represent the densitometric analysis of three independent ex-
periments and are expressed as % control (mean þ S.E.M.). Data
were compared versus untreated cells by Student’s test; *P6 0.05.
Fig. 4. Role of p38MAPK on TGF-L-induced caspase activation.
A,B: Fetal hepatocytes were treated for 15 h without or with 2 ng/
ml TGF-L and without or with PD169316 (400 nM), cells were
lysed and caspase-3 (A) and caspase-8 (B) assayed. Results are ex-
pressed as units/Wg protein and are mean þ S.E.M. of three inde-
pendent experiments with duplicate dishes. Data were compared ver-
sus untreated cells by Student’s test; *P6 0.01; **P6 0.001.
C: Cells were incubated for 15 h or 20 h under the same conditions
described in A. After this time, total proteins were extracted and
the levels of Bid analyzed by Western blot. Albumin content was as-
sayed as control. A representative experiment of three is shown.
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3.3. p38MAPK is dispensable for the regulation of Bcl-xL levels
and cytochrome c release induced by TGF-L
We next decided to analyze whether p38MAPK is involved
in the regulation of Bcl-xL expression. Fig. 3A shows that Bcl-
xL levels decreased in response to TGF-L, regardless the pres-
ence of the p38MAPK inhibitor. To know if p38MAPK could
mediate other processes, independently on Bcl-xL, which acti-
vate cytochrome c release from mitochondria, we next studied
the cytochrome c mitochondrial content. As shown in Fig. 3B,
the p38MAPK inhibitor did not a¡ect the mitochondrial de-
pletion of cytochrome c induced by TGF-L in fetal hepato-
cytes.
3.4. p38MAPK is dispensable for caspase activation and loss of
cell viability induced by TGF-L
Finally, we analyzed whether p38MAPK is involved in the
activation of caspase-8 and/or caspase-3 by a mitochondria-
independent mechanism. TGF-L activated caspase-3 (4-fold
control values) and caspase-8 (2.5-fold control values) (Fig.
4). The presence of PD169316 slightly attenuated the activa-
tion in both cases, with a higher e¡ect on caspase-8. In order
to know the relevance of this e¡ect on the cleavage of caspase-
8 substrates, we analyzed the levels of Bid, which has been
described as an important substrate of caspase-8 [23,24]. Bid
levels considerably decreased after incubation with TGF-L,
regardless the presence of the p38MAPK inhibitor (Fig. 4C).
In agreement with the results presented in Figs. 3 and 4,
p38MAPK inhibition was not able to rescue fetal hepatocytes
from the cell death induced by TGF-L (Fig. 5).
4. Discussion
The TGF-L family of polypeptide factors is capable of reg-
ulating several cellular processes, including proliferation, lin-
eage determination, di¡erentiation, motility, adhesion and
death [25]. Some of the TGF-L actions may be mediated by
oxidative stress. This cytokine activates an H2O2-generating
NADH oxidase [26] and down-regulates the expression of
antioxidative enzymes [27], which increase ROS intracellular
content [2,27^30]. ROS appear to be involved in the apoptosis
mediated by this factor [2^4,29] and in some of its transcrip-
tional e¡ects [28,30]. However, the mechanisms by which ROS
mediate these e¡ects are not completely understood.
The p38 subfamily of MAPKs was ¢rst associated with
stress responses but it can mediate di¡erent cellular functions,
such as growth, di¡erentiation and apoptosis [6^8]. Results
presented in this paper indicate that TGF-L activates
p38MAPK (Fig. 1) and ROS may be responsible for this
activation (Fig. 2). Firstly, activation of p38MAPK occurs
late, coincident with the maximal production of ROS [2,4].
Secondly, the presence of radical scavengers (such as ASC
and PDTC) blocks this activation and the presence of gluta-
thione synthesis inhibitors, such as BSO, accentuates the ef-
fect. Finally, the incubation of fetal hepatocytes in the pres-
ence of TBH alone produces an early activation of
p38MAPK. Since ROS are responsible for the down-regula-
tion of Bcl-xL expression, mitochondrial collapse and cell
death induced by TGF-L in fetal hepatocytes [2^4], it seemed
attractive to hypothesize that p38MAPK would mediate the
response to ROS in terms of apoptosis. However, we have not
observed any involvement of p38MAPK on any of the mito-
chondrial-dependent apoptotic events (Fig. 3B). Furthermore,
although the p38MAPK inhibitor slightly attenuates caspase-
8 activity, neither the cleavage of Bid, nor the loss of cell
viability is a¡ected by the p38MAPK inhibitor (Figs. 4 and 5).
p38MAPKs have been proposed as regulators of apoptosis
[9^14]. However, it is worthy to note that, although there are
more and more evidences for the involvement of oxidative
stress in the activation of p38MAPKs [31^33], it is not so
clear that these kinases mediate the cytotoxicity induced by
ROS. Treatment of HeLa cells with H2O2 resulted in sus-
tained activation of p38MAPK, but inhibition of this pathway
had no e¡ect on cell survival [31]; activation of p38MAPK by
chromium(VI) is mediated through oxidative stress but does
not a¡ect cytotoxicity [34] ; and in U937 human lymphoid
cells a low dose of H2O2 rapidly causes p38MAPK cascade
activation, causing mitotic arrest, but lacking apoptosis induc-
tion. Zhuang et al. have recently proposed in human leukemia
cells that the involvement of p38MAPK in the apoptosis in-
duced by oxidative stress is dependent on the ROS produced
[35]. Thus, although both singlet oxygen and hydrogen per-
oxide selectively stimulate the phosphorylation of p38, this
MAPK mediates Bid cleavage and caspase-3 activation during
the apoptosis induced by singlet oxygen but not by hydrogen
peroxide [35].
Which could be the role of this ROS-mediated p38MAPK
activation? It has recently been described that p38MAPK
plays a critical role in arresting growth of hepatocytes in
near-term fetal rats [36]. However, the possible role of
p38MAPK mediating growth arrest by TGF-L in fetal hepa-
tocytes appears improbable because p38MAPK is not acti-
vated by low concentrations of the cytokine (Fig. 1), enough
to arrest growth but not to induce ROS production and ap-
optosis [22]. Furthermore, results in our laboratory indicate
that TGF-L continues arresting growth of fetal hepatocytes in
the presence of the p38MAPK inhibitor (results not shown). It
has also been suggested that p38MAPK could play a role in
the TGF-L-induced chemotactic responses [15] and regulation
of gene expression [16^19]. Since ROS appear to be also in-
Fig. 5. p38MAPK is dispensable for TGF-L-induced cell death.
After 24 h incubation of fetal hepatocytes without or with 2 ng/ml
TGF-L and without or with PD169316 (400 nM), cell viability was
analyzed. Results are expressed as % of control, untreated cells. The
means þ S.E.M. of triplicate dishes from ¢ve independent experi-
ments are shown. Data were compared versus untreated cells by
Student’s test; *P6 0.001.
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volved in some of these transcriptional e¡ects [28,30], we
could speculate that p38MAPK might mediate ROS regula-
tion of gene expression by TGF-L. Further work will be nec-
essary to con¢rm this hypothesis.
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